FDA Calls For Uniform Name For Biogenerics
The U.S. Food and Drug Administration has ruled out "biogenerics" as a name for generic versions of biotech drugs and will require that any official term for the class of drugs...To view the full article, register now.
Already a subscriber? Click here to view full article